State
72,919 recalls have nationwide distribution and so reach Vermont. 1,983 additional recalls listed Vermont specifically in their distribution scope.
Of the 1,983 recalls naming Vermont we have scored against our rubric, 199 (10%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 409 (21%) are Severe.
Which agencies issued them
These figures cover only the 1,983 recalls whose distribution notice names Vermont specifically. The 72,919 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.
Fresenius Kabi is recalling 0.9% Sodium Chloride Injection, USP in 50 mL presentation, citing lack of assurance of sterility. Two batches are affected.
A circuit board issue in Multi-parameter Command Module model 91496 can start cardiac output measurement early in Auto mode, producing errors and inaccurate readings. 1,790 units are affected.
Fagron Sterile Services is recalling Vancomycin HCl 1 gram in 250 mL sodium chloride bags for lack of assurance of sterility and because a blue break-off part could detach from the administration port.
Fresenius Kabi is recalling 0.45% Sodium Chloride Injection, USP in 250 mL freeflex bags, citing lack of assurance of sterility.
Fresenius Kabi is recalling 0.9% Sodium Chloride Injection, USP in 100 mL single dose freeflex bags distributed by BD, citing lack of assurance of sterility.
GE Healthcare is recalling Omnipaque (iohexol) Injection, 300 mg/mL, over the presence of particulate matter. The action covers 866,570 vials distributed nationwide.
Fagron is recalling Vancomycin HCl 1.25 grams in 250 mL sodium chloride bags for lack of assurance of sterility and because a blue break-off part could detach from the administration port.
Fresenius Kabi is recalling 0.9% Sodium Chloride Injection, USP in 50 mL presentation distributed by BD, citing lack of assurance of sterility.
Fagron is recalling norepinephrine bitartrate 32 mg in 250 mL sodium chloride bags for lack of assurance of sterility and because a blue break-off part could detach from the administration port.
Preferred Pharmaceuticals is recalling six lots of Artificial Tears Lubricant Eye Drops manufactured by Geri-Care, citing lack of assurance of sterility. 720 bottles are affected.
Fagron is recalling norepinephrine bitartrate 16 mg in 250 mL sodium chloride bags for lack of assurance of sterility and because a blue break-off part could detach from the administration port.
Fresenius Kabi is recalling three batches of 5% Dextrose Injection, USP, 5 g per 100 mL in freeflex bags, citing lack of assurance of sterility.
Fresenius Kabi is recalling 0.9% Sodium Chloride Injection, USP in 1,000 mL single dose freeflex bags distributed by Fresenius Medical Care RTG, citing lack of assurance of sterility.
Siemens ARTIS pheno and ARTIS Icono systems may sporadically display a major increase in the x-ray dose applied, although the actual dose applied remains within system settings and regulatory limits.
Ford is recalling 2015-2017 F-150 vehicles because a signal loss can cause unexpected downshifting, increasing crash risk. Dealers will update software free of charge.
Ford is recalling certain 2025-2026 F-59 and F-53 vehicles because the front axle hub assembly may be missing the spindle nut and cotter pin, which can lead to wheel detachment.
Ford is recalling certain 2021-2025 Bronco vehicles because a misaligned transmission to transfer case joint can wear the splines, potentially causing loss of drive power or rollaway.
Ford is recalling 2024-2026 Ranger vehicles because improperly positioned sun visor or headliner wiring harnesses may cause an electrical short and fire in the A-pillar area.
Ford is recalling certain 2026 Bronco Sport vehicles with a 1.5L or 2.0L MPC engine and block heater because the heater may overheat when plugged in while parked, increasing fire risk.
Harley-Davidson is recalling certain 2025–2026 Softail motorcycles because the rear brake line may contact the Body Control Module, causing a brake fluid leak and loss of rear brakes. Loss of rear brakes increases crash risk.
Jayco is recalling 2025-2026 Entegra Ethos recreational vehicles because incorrect seat belt labels may lead to unbelted passengers, increasing injury risk in crashes.
Kia is recalling certain 2022–2026 Carnival vehicles because fuel may leak at the pipe connection between the fuel pipe and fuel rail, increasing the risk of fire.
Hyundai Motor America is recalling certain Genesis GV70, G80, G90, and GV80 vehicles from 2021–2026 due to a fuel leak risk at the pipe connection between the fuel pipe and fuel rail, which increases the risk of fire.
Bentley is recalling 2026 Bentayga vehicles because the tire placard displays an incorrect maximum capacity weight, which may lead to unintentional overloading.
Nissan is recalling 2009-2010 Cube vehicles because the driver's air bag inflator may rupture or detach during deployment, posing an injury risk.